Trabectedin First Line Therapy In Unfit Sarcoma Study

Clinical trial NCT02066675 · COMPLETED

Trial details

NCT number: NCT02066675
Sponsor: Italian Sarcoma Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive Standard Chemotherapy

Start date: 2014-02-01
Primary completion: 2016-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.